cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Cormedix Inc
7 own
19 watching
Current Price
$4.48
$0.04
(0.9%)
logo-crmd
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
184.61M
52-Week High
52-Week High
8.025
52-Week Low
52-Week Low
2.645
Average Volume
Average Volume
0.31M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization184.61M
icon52-Week High8.025
icon52-Week Low2.645
iconAverage Volume0.31M
iconDividend Yield--
iconP/E Ratio--
What does the Cormedix Inc do?
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
Read More
How much money does Cormedix Inc make?
News & Events about Cormedix Inc.
Globe Newswire
17days ago
BERKELEY HEIGHTS, N.J., Jan. 17, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases, today announced the following promotions ...
Globe Newswire
1month ago
BERKELEY HEIGHTS, N.J., Dec. 06, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases, today announced the abstract publication ...
Globe Newswire
2 months ago
NEW YORK, Nov. 19, 2022 (GLOBE NEWSWIRE) -- Okta, Inc. (NASDAQ: OKTA) Lifshitz Law PLLC announces that a class action complaint was filed on behalf of shareholders of Okta alleging that Defendants made materially false and misleading statements regarding the Companys business, operations, and ...
Globe Newswire
2 months ago
BERKELEY HEIGHTS, N.J., Nov. 07, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases, today announced that the Center for ...
Globe Newswire
4 months ago
BERKELEY HEIGHTS, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that management will be ...
Frequently Asked Questions
Frequently Asked Questions
What is Cormedix Inc share price today?
plus_minus_icon
Can Indians buy Cormedix Inc shares?
plus_minus_icon
How can I buy Cormedix Inc shares from India?
plus_minus_icon
Can Fractional shares of Cormedix Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Cormedix Inc stocks?
plus_minus_icon
What is today’s traded volume of Cormedix Inc?
plus_minus_icon
What is today’s market capitalisation of Cormedix Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Cormedix Inc?
plus_minus_icon
What percentage is Cormedix Inc down from its 52-Week High?
plus_minus_icon
What percentage is Cormedix Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$4.48
$0.04
(0.9%)
logo-crmd
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00